Stocks
Arcutis Biotherapeutics (ARQT) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -8 025% | -401.3% | -178.5% | |||||
| Changes by years, y/y, % | +7 624pp | -95.0% | |||||||
Arcutis Biotherapeutics. EBITDA margin, %
Arcutis Biotherapeutics. EBITDA margin, changes, pp
Arcutis Biotherapeutics (ARQT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -2 627% | -1 226% | -89.7% | -449.4% | -63.1% | -178.5% | |
| Changes by years, y/y, % | +14 052pp | +1 749pp | +2 564pp | |||||
| Changes by quarters, q/q, % | -428pp | +1 401pp | +1 137pp | -360pp | +386pp | |||
